Laura C Coates, Josef S Smolen, Philip J Mease, et al.
Issues - Ottobre 2022
Laura C Coates, Josef S Smolen, Philip J Mease, et al.
Andrew Blauvelt, Nianwen Shi, Russel Burge, et al.
Healthcare costs among patients with psoriasis treated with ixekizumab versus secukinumab in real-world settings over 24 months
Pharmacoecon Open. 2022 Sep 26. Online ahead of printNeslihan Demirel Öğüt, Sema Koç Yıldırım, Ece Erbağcı, et al.
Ixekizumab treatment in patients with moderate-to-severe plaque psoriasis in a real-world clinical setting
J Cosmet Dermatol. 2022 Jul 8. Online ahead of printKoji Kamiya, Mamitaro Ohtsuki
Epidemiological survey of patients with pustular psoriasis in the Japanese Society for Psoriasis Research from 2017 to 2020
J Dermatol. 2022 Sep 24. Online ahead of printGeeta Yadav, Jensen Yeung, Yvette Miller-Monthrope, et al.
Unmet need in people with psoriasis and skin of color in Canada and the United States
Dermatol Ther (Heidelb). 2022 Sep 21. Online ahead of printSamantha Sarabia, Brandan Ranjith, Sahil Koppikar, et al.
Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis
BMC Rheumatol. 2022 Sep 27;6(1):71Melek Aslan Kayıran, Ayşe Serap Karadağ, İlteriş Oğuz Topal, et al.
Habits of using social media and the internet in psoriasis patients
Dermatol Pract Concept. 2022 Jul 1;12(3):e2022143Alessandra Narcisi, Mario Valenti, Luigi Gargiulo, et al.
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: a 52-week multicenter retrospective study – IL PSO (ITALIAN LANDSCAPE PSORIASIS)
J Eur Acad Dermatol Venereol. 2022 Sep 26. Online ahead of printNeuza da Silva, Matthias Augustin, Caroline Hilbring, et al.
Psychological (co)morbidity in patients with psoriasis: the impact of pruritus and anogenital involvement on symptoms of depression and anxiety and on body dysmorphic concerns – a cross-sectional study
BMJ Open. 2022 Sep 23;12(9):e055477Marta Olejárová, Želmíra Macejová, Spyridon Gkalpakiotis, et al.
Reproductive healthcare in women with rheumatoid arthritis and psoriatic diseases in routine clinical practice: survey results of rheumatologists and dermatologists
Rheumatol Ther. 2022 Sep 24. Online ahead of printAkimichi Morita, Yukie Yamaguchi, Chiharu Tateishi, et al.
Efficacy and safety of apremilast and phototherapy versus phototherapy only in psoriasis vulgaris
J Dermatol. 2022 Sep 24. Online ahead of printKacper Nijakowski, Dawid Gruszczyński, Julia Kolasińska, et al.
Periodontal disease in patients with psoriasis: a systematic review
Int J Environ Res Public Health. 2022 Sep 8;19(18):11302Joel M Gelfand, Daniel B Shin, April W Armstrong, et al.
Association of apremilast with vascular inflammation and cardiometabolic function in patients with psoriasis: the VIP-A Phase 4, open-label, nonrandomized clinical trial
JAMA Dermatol. 2022 Sep 21. Online ahead of printMark G Lebwohl, Leon H Kircik, Angela Y Moore, et al.
Effect of roflumilast cream vs vehicle cream on chronic plaque psoriasis: the DERMIS-1 and DERMIS-2 randomized clinical trials
JAMA. 2022 Sep 20;328(11):1073-1084Ranju Pokharel, Sudha Agrawal, Prajwal Pandey, et al.
Assessment of vitamin D level in patients with psoriasis and its correlation with disease severity: a case-control study
Psoriasis (Auckl). 2022 Sep 13;12:251-258.Shuo Zhang, Jiao Wang, Liu Liu, et al.